Corporate News     23-Jan-23
Marksans Pharma receives UK MHRA approval for Fluoxetine 20mg/5ml Oral Solution
Marksans Pharma announced that UK MHRA has granted Market Authorisation to the Company's wholly owned subsidiary Relonchem Limited for Fluoxetine 20mg/5ml Oral Solution.

Therapeutic use of the product is for treatment of depressive illness and other mental/mood disorders.

The product will be manufactured at the plant of Bell, Sons & Co. (Druggists) located at Gifford House, Slaidburn Crescent, Southport, UK.

Previous News
  Marksans Pharma consolidated net profit declines 4.44% in the March 2024 quarter
 ( Results - Announcements 30-May-24   12:46 )
  Board of Marksans Pharma recommends final dividend
 ( Corporate News - 31-May-23   12:46 )
  Marksans Pharma spurts as Q2 PAT rises 30% YoY
 ( Hot Pursuit - 15-Nov-22   10:42 )
  Marksans Pharma standalone net profit declines 20.73% in the December 2017 quarter
 ( Results - Announcements 12-Feb-18   17:07 )
  Marksans Pharma to announce Quarterly Result
 ( Corporate News - 01-Aug-19   11:02 )
  Marksans Pharma consolidated net profit rises 34.64% in the September 2022 quarter
 ( Results - Announcements 15-Nov-22   08:45 )
  Nifty below 17,400 level; bank stocks under pressure
 ( Market Commentary - Mid-Session 10-Mar-23   14:37 )
  Marksans Pharma receives UK MHRA approval for Fluoxetine 20mg/5ml Oral Solution
 ( Corporate News - 23-Jan-23   13:41 )
  Marksans Pharma consolidated net profit rises 31.37% in the December 2022 quarter
 ( Results - Announcements 13-Feb-23   14:08 )
  Marksans Pharma rallies 25.86% in two sessions
 ( Hot Pursuit - 21-Feb-17   11:53 )
  Marksans Pharma fixes record date for dividend
 ( Market Beat - Reports 24-May-23   17:38 )
Other Stories
  Tinna Trade raises Rs 49 cr to fund its growth plans
  06-Jul-24   11:10
  Integra Essentia announces merger with G G Engineering
  06-Jul-24   11:05
  Ugro Capital to raise Rs 75 cr via NCD issuance
  06-Jul-24   10:58
  Board of D.P. Abhushan approves preferential allotment of shares and warrants
  06-Jul-24   10:50
  Life Insurance Corporation of India invest Rs 14 cr in Sri Lankan subsidiary
  06-Jul-24   10:49
  High Energy Batteries (India) to discuss results
  06-Jul-24   10:29
  Havells India schedules board meeting
  06-Jul-24   10:29
  Axis Bank announces board meeting date
  06-Jul-24   10:29
  Mastek to conduct board meeting
  06-Jul-24   10:29
  Oriental Hotels to conduct board meeting
  06-Jul-24   10:29
Back Top